Ernexa Therapeutics appoints former Schering-Plough CMO Robert J. Spiegel to board
ERNA•Company context
The appointment comes as the company advances ERNA-101 toward clinical development.
Board appointment and background
Ernexa Therapeutics appointed Robert J. Spiegel to its board of directors.
Spiegel previously served as chief medical officer at Schering-Plough Research Institute from 1998 to 2009. He later held a chief medical officer role at PTC Therapeutics from 2014 to 2016.
Spiegel is founder and principal of Spiegel Consulting LLC, and also an associate professor at Weill Cornell Medical College.
